Effect of genetic polymorphism on individualized treatment of tacrolimus in patients with primary nephrotic syndrome
As a highly effective immunosuppressant, tacrolimus(TAC,FK506)has been widely applied for primary nephrotic syndrome.However, excessive dose or underexposure of TAC remains rampant in clinical practices.Recent studies have indicated that cytochrome P450 family 3 subfamily A4(CYP3 A4),cytochrome P450...
Saved in:
| Main Authors: | Xiong Lian-lian, Yi Bin |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57903734&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship of TNFα-308A/G polymorphism with primary nephrotic syndrome
by: XIANG Xin, et al.
Published: (2017-01-01) -
The safety of cyclosporine and tacrolimus in pediatric nephrotic syndrome patients: a disproportionate analysis based on the FAERS database
by: Yu Liu, et al.
Published: (2025-01-01) -
Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials
by: Jessica Felicia Ang, et al.
Published: (2024-04-01) -
The relationship between tacrolimus concentration-dose ratio and genetic polymorphism in patients subjected to renal transplantation
by: Rančić Nemanja, et al.
Published: (2018-01-01) -
Tacrolimus Therapy Among Steroid-Resistant Nephrotic Syndrome Children: A Preliminary Study in West Java, Indonesia
by: Ahmedz Widiasta, et al.
Published: (2024-09-01)